Prelude(FRANCE) | $8,000,000 | (Nov 14, 2024)
Camouflet | $3,000,000 | (Nov 14, 2024)
CHAOS Industries | $145,000,000 | (Nov 14, 2024)
Certified by Founder
Lodge
TRexBio
start up
United States
- South San Francisco, California
- 14/11/2024
- Series B
- $84,000,000
TRexBio is a discovery stage biotechnology company leveraging cutting edge computational biology tools, a focus on human tissue, and expertise in immunobiology to develop revolutionary therapeutics for cancer and inflammatory diseases. Our powerful ‘deep biology’ discovery engine maps human tissue Treg behavior to disease processes, allowing us to identify and characterize novel targets for therapeutic intervention. Leveraging this platform, we are building a broad portfolio of novel therapies that modulate the immune system to restore human tissue immune homeostasis. TRexBio is headquartered in South San Francisco, California.
- Industry Biotechnology Research
- Website https://trex.bio/
- LinkedIn https://www.linkedin.com/company/trexbio-inc/
Arbolus | $20,000,000 | (Nov 14, 2024)
Trolley | $23,000,000 | (Nov 14, 2024)
Notabene | $14,500,000 | (Nov 14, 2024)
Pikndel | $1,000,000 | (Nov 14, 2024)
Zeplyn | $3,000,000 | (Nov 14, 2024)
High Basin Brands | $4,000,000 | (Nov 14, 2024)
Metsera | $215,000,000 | (Nov 14, 2024)
InVintory | $2,300,000 | (Nov 14, 2024)